Evidence map›Paper›PMID 26339258›Full record

ArticleResearch in pharmaceutical sciences

Identification and characterization of a compound from Cuminum cyminum essential oil with antifibrilation and cytotoxic effect.

D Morshedi, T Salmani Kesejini, F Aliakbari, R Karami-Osboo, M Shakibaei, A Tayaranian Marvian, M Khalifeh, M Soroosh

Open access · greenAbstract read
In one paragraph

Article in Research in pharmaceutical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

D MorshediDepartment of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, I.R. Iran.
T Salmani KesejiniDepartment of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, I.R. Iran.
F AliakbariDepartment of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, I.R. Iran ; Department of Medical Biotechnology, Semnan University of Medical Sciences, Semnan, I.R. Iran.
R Karami-OsbooMedicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
M ShakibaeiDepartment of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, I.R. Iran.
A Tayaranian MarvianDepartment of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, I.R. Iran ; Department of Cell and Molecular Biology, School of Biology, University College of Science, University of Tehran, Tehran, I.R. Iran.
M KhalifehDepartment of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, I.R. Iran.
M SorooshDepartment of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, I.R. Iran.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid pathology is associated with fibril aggregation of different proteins which results in the progressive damage of affected organs. It is strongly believed that specific small molecules interfere with fibrillation by interacting with the amyloidogenic proteins. We had previously reported the strong and long-term inhibition of fibrillation of hen egg white lysozyme (HEWL) by Cuminum cyminum oil. Herein, it was intended to rationally identify the active anti-amyloidogenic compounds of the oil. After fractionation, the highest inhibitory effect was observed in the toluene-ethyl acetate part of the oil. Gas chromatography-mass spectrometry (GC-MS) analysis of this fraction indicated that eight compounds were predominantly present in the fraction. Unexpectedly, two compounds including terpinolene and limonene, having very similar chemical structures, inhibited and induced fibrillation, respectively. PC12 cells (derived from a transplantable rat pheochromocytoma) were affected by HEWL fibrils, whereas the inhibited forms of fibrils in the presence of terpinolene led to higher levels of viability, as shown by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), lactate dehydrogenase (LDH) and flow cytometry assays. Molecular local docking analysis suggested a site of interaction for terpinolene in the flexible cleft of the protein. This interaction site is close to tryptophan -62 and -63 and two other hydrophobic residues in the hot spot regions of the protein. Seemingly, these interactions interrupt protein self-assembly and therefore, fibril formation. Despite previously reported small anti-amyloid molecules which have aromatic flat rings, terpinolene ring is not flat. This functionally durable small molecule may aid us toward developing new anti-amyloidogenic compounds with extended activity.

Indexed as

Anti-fibrillation compoundsEssential oil fractionationHEWL fibrillationIranian Cuminum cyminumLocal docking

Identifiers

PMID26339258
PMCPMC4326981
OpenAlexW2144997175

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.